Deepak Kanojia Selected Research

Deepak Kanojia Research Topics

Disease

27	Neoplasms (Cancer) 04/2024 - 08/2006
13	Glioma (Gliomas) 01/2023 - 01/2015
12	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2012
11	Brain Neoplasms (Brain Tumor) 10/2023 - 05/2015
6	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2015
6	Carcinogenesis 01/2021 - 08/2006
5	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2012
3	Disease Progression 02/2024 - 10/2020
3	Triple Negative Breast Neoplasms 02/2024 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2022
1	Adenocarcinoma 01/2023
1	Squamous Cell Carcinoma of Head and Neck 03/2022
1	Necrosis 01/2020
1	Circulating Neoplastic Cells 12/2019
1	Mouth Neoplasms (Oral Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2012
4	Phosphotransferases (Kinase)IBA 02/2024 - 01/2022
4	human ERBB2 proteinIBA 01/2022 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2006
3	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2023
3	CytokinesIBA 02/2024 - 01/2021
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2015
2	Single-Domain AntibodiesIBA 01/2022 - 12/2019
2	AntibodiesIBA 01/2022 - 10/2015
2	tucatinibIBA 01/2022 - 10/2020
2	ChemokinesIBA 01/2021 - 10/2016
2	TubulinIBA 01/2020 - 05/2015
2	AntigensIBA 01/2020 - 10/2018
2	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 12/2019 - 08/2006
2	SurvivinIBA 01/2016 - 09/2015
2	CarcinogensIBA 01/2012 - 08/2006
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	CaspasesIBA 10/2023
1	methixene (metixene)FDA Link 10/2023
1	EnzymesIBA 01/2023
1	Checkpoint Kinase 1IBA 01/2023
1	Hyaluronic Acid (Hyaluronan)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 03/2022
1	signal sequence receptorIBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	pertuzumabIBA 01/2022
1	taxaneIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	InterferonsIBA 01/2021
1	LymphokinesIBA 01/2021
1	InterleukinsIBA 01/2021
1	Tumor Necrosis FactorsIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 10/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020
1	Amino Acids FDA Link 01/2020
1	Tryptophan (L-Tryptophan)FDA Link 01/2020
1	B7-H1 AntigenIBA 11/2019
1	Lipid NanoparticlesIBA 11/2019
1	LigandsIBA 07/2019
1	Fatty Acid-Binding Protein 7IBA 01/2019
1	IntegrinsIBA 01/2019
1	Therapeutic UsesIBA 07/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 06/2017
1	OsteoprotegerinIBA 10/2016
1	Peptides (Polypeptides)IBA 09/2015
1	NestinIBA 05/2015
1	3-hydroxyphenyltrimethylammoniumIBA 11/2012
1	Keratins (Keratin)IBA 01/2012
1	cholanthreneIBA 08/2006
1	Coal Tar (Estar)IBA 08/2006
1	9,10-Dimethyl-1,2-benzanthraceneIBA 08/2006

Therapy/Procedure

22	Therapeutics 02/2024 - 01/2013
5	Oncolytic Virotherapy 07/2017 - 01/2015
3	Radiotherapy 01/2022 - 01/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
1	Cranial Irradiation 01/2022
1	Precision Medicine 01/2022
1	Immunotherapy 11/2019
1	Immunomodulation 10/2017
1	Biological Therapy 01/2016
1	Chemoradiotherapy 03/2015